Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2026-02-28 @ 12:29 PM
Study NCT ID:
NCT00486759
Status:
TERMINATED
Last Update Posted:
2017-07-25
First Post:
2007-06-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07-26
Start Date Type:
ACTUAL
Primary Completion Date:
2011-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-14
First Submit QC Date:
None
Study First Post Date:
2007-06-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-11-28
Results First Submit QC Date:
None
Results First Post Date:
2012-12-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-26
Last Update Post Date:
2017-07-25
Last Update Post Date Type:
ACTUAL